Nonalcoholic fatty liver disease (NAFLD) is emerging globally as the major cause of chronic liver disease,
1 with a prevalence of approximately 30% in the general population and 80% among morbidly obese individuals.
2,3 Lifestyle factors, including unhealthy diet and lack of physical activity, play a key role in the onset of NAFLD
4,5 and their modification is the standard treatment.
6 Insulin resistance, type 2 diabetes, and obesity are the strongest risk factors for NAFLD.
1 However, a reciprocal association is also evident,
7 in which NAFLD may lead to type 2 diabetes and metabolic syndrome independently from body weight
8-12 or even visceral adiposity.
13